Rituximab Targets Podocytes in Recurrent Focal Segmental Glomerulosclerosis

Addition of anti-CD25 to thymoglobulin for induction therapy: delayed return of peripheral blood CD25-positive population

(2010) Junichiro Sageshima et al.   CLINICAL TRANSPLANTATION

Specialized roles for cysteine cathepsins in health and disease

(2010) Jochen Reiser et al.   JOURNAL OF CLINICAL INVESTIGATION

Evolution of anti- CD20 monoclonal antibody therapeutics in oncology

(2010) Ezogelin Oflazoglu et al.   mAbs

Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era

(2009) Grzegorz S. Nowakowski et al.   JOURNAL OF CLINICAL ONCOLOGY

Podocyte Glutamatergic Signaling Contributes to the Function of the Glomerular Filtration Barrier

(2009) L. Giardino et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Proteinuria: an enzymatic disease of the podocyte?

(2009) Peter Mundel et al.   KIDNEY INTERNATIONAL

Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation

(2009) C. Ponticelli   NEPHROLOGY DIALYSIS TRANSPLANTATION

Use of Rituximab in Focal Glomerulosclerosis Relapses After Renal Transplantation

(2009) Luca Dello Strologo et al.   TRANSPLANTATION

Kidney Transplantation for Primary Focal Segmental Glomerulosclerosis: Outcomes and Response to Therapy for Recurrence

(2009) LaTonya J. Hickson et al.   TRANSPLANTATION

Increase of Integrin-Linked Kinase Activity in Cultured Podocytes upon Stimulation with Plasma from Patients with Recurrent FSGS

(2008) M. Hattori et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

(2008) Christian Faul et al.   NATURE MEDICINE

Rituximab for post-transplant recurrences of FSGS

(2008) Umut Selda Bayrakci et al.   PEDIATRIC TRANSPLANTATION